Aspro. Ekene Nweke

Ekene Nweke is a cancer researcher whose work centers on precision oncology and translational cancer biology, with a strong focus on African patient populations. Affiliated with South African academic and clinical institutions, Nweke contributes to multidisciplinary collaborations addressing disparities in cancer outcomes through molecular profiling and functional drug testing approaches.

Research highlights include the development of ex vivo drug sensitivity screening platforms for leukemia and other malignancies, advancing personalized treatment strategies and drug repurposing in resource-constrained settings. Studies in pancreatic ductal adenocarcinoma and gallbladder cancer integrate immunology, proteomics, and pathway analysis to uncover biomarkers and therapeutic targets, particularly within cohorts of African ancestry.

Additional contributions span immune profiling, complement pathway biology, hepatopancreatobiliary cancers, and clinically oriented surgical research. This body of work reflects strengths in translational methodology, biomarker discovery, and the application of laboratory insights to patient-centered cancer care, reinforcing precision medicine initiatives across the African continent.